Ticker Details
Fortress Biotech, Inc. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products.
IPO Date:	December 1, 2011
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$99.66M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 4.34%
Avg Daily Range (30 D):	$0.12 | 4.16%
Avg Daily Range (90 D):	$0.09 | 3.30%

Institutional Daily Volume
Avg Daily Volume:	.13M
Avg Daily Volume (30 D):	.49M
Avg Daily Volume (90 D):	.44M

Trade Size
Avg Trade Size (Sh.):	81
Avg Trade Size (Sh.) (30 D):	160
Avg Trade Size (Sh.) (90 D):	165

Institutional Trades
Total Institutional Trades:	39
Avg Institutional Trade:	$2.27M
Avg Institutional Trade (30 D):	$.5M
Avg Institutional Trade (90 D):	$.5M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.49M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	11.5K

News

Oct 1, 2025 @ 7:45 PM Fortress Biotech Investigated by the Portnoy Law F... Source: Lesley F. Portnoy

Oct 1, 2025 @ 12:00 PM Fortress Biotech and Cyprium Therapeutics Annou... Source: Fortress Biotech, Inc.

May 30, 2025 @ 2:47 PM Fortress Biotech Announces Closing of Sale of Subs... Source: Globe Newswire

May 7, 2025 @ 12:00 PM Fortress Biotech to Participate in the H.C. Wainwr... Source: N/A

Feb 10, 2025 @ 1:00 PM Mustang Bio Announces Closing of $8 Million Public... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$3.84	$3.44	$-.23
Diluted EPS	$3.17	$2.82	$-.21
Revenue	$66.16M	$16.04M	$16.08M
Gross Profit	$43.81M	$9.82M	$10.64M
Net Income / Loss	$128.94M	$137.16M	$-5.4M
Operating Income / Loss	$-55.81M	$-7.74M	$-4.79M
Cost of Revenue	$22.35M	$6.22M	$5.44M
Net Cash Flow	$-11.96M	$M	$-6.84M
PE Ratio

Splits
Oct 10, 2023	1:15
Dec 06, 2022	1:10